Smartphone and fitbit data may forecast COPD attacks

NCT ID NCT06118632

First seen Aug 11, 2026 · Last updated Aug 12, 2026 · Updated 1 time

Summary

This study is testing whether a smartphone app and a Fitbit can detect early warning signs of a COPD flare-up. Around 300 people with COPD will be monitored for three months after leaving the hospital. The goal is to see if remote measurements of vital signs and symptoms can predict a decline in health, potentially allowing doctors to intervene early and prevent hospital readmission.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Remote monitoring with a smartphone app and Fitbit device
What this could lead to
If successful, this could enable early intervention for COPD flare-ups, potentially reducing hospital readmissions and improving patient outcomes.
What could go wrong
This is an observational study, so it won't test a treatment. The technology may not reliably predict exacerbations, and data quality or patient adherence could be challenges.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COPD EXACERBATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Chelsea and Westminster Hospital

    London, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.